-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss).
-
Summary
-
OptimizeRx Corp quarterly/annual Revenues history and growth rate from 2010 to 2024.
- OptimizeRx Corp Revenues for the quarter ending December 31, 2024 was $32.3M, a 13.9% increase year-over-year.
- OptimizeRx Corp Revenues for the twelve months ending December 31, 2024 was $92.1M, a 28.8% increase year-over-year.
- OptimizeRx Corp annual Revenues for 2024 was $92.1M, a 28.8% increase from 2023.
- OptimizeRx Corp annual Revenues for 2023 was $71.5M, a 14.5% increase from 2022.
- OptimizeRx Corp annual Revenues for 2022 was $62.5M, a 1.89% increase from 2021.